As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

Novartis, Eli Lilly and more put on their deal-making caps, Bristol Myers Squibb targets $2 billion in savings through 2027, sales continue to soar for Lilly and Novo Nordisk’s GLP-1s and Regeneron ...

We recently compiled a list of the 12 Best International Dividend Stocks To Buy Now. In this article, we are going to take a ...

Lyft (NASDAQ: LYFT) fell 10% after its guidance disappointed investors. The company sees first quarter gross bookings growth ...